XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balances (in shares) at Dec. 31, 2022 3,737,921        
Balances at Dec. 31, 2022 $ 1 $ 196,252 $ (193,219) $ 203 $ 3,237
Stock-based compensation expense 0 2,223 0 0 2,223
Unrealized loss on available-for-sale securities 0 0 0 14 14
Foreign currency translation adjustments 0 0 0 4 4
Net loss $ 0 0 (11,770) 0 (11,770)
Issuance of common stock (in shares) 161,388        
Issuance of common stock $ 0 4,664 0 0 4,664
Balances (in shares) at Mar. 31, 2023 3,899,309        
Balances at Mar. 31, 2023 $ 1 203,139 (204,989) 221 (1,628)
Balances (in shares) at Dec. 31, 2022 3,737,921        
Balances at Dec. 31, 2022 $ 1 196,252 (193,219) 203 3,237
Balances (in shares) at Jun. 30, 2023 6,419,998        
Balances at Jun. 30, 2023 $ 1 251,484 (230,132) 174 21,527
Balances (in shares) at Dec. 31, 2022 3,737,921        
Balances at Dec. 31, 2022 $ 1 196,252 (193,219) 203 3,237
Foreign currency translation adjustments         (130)
Net loss         (39,331)
Balances (in shares) at Sep. 30, 2023 6,420,541        
Balances at Sep. 30, 2023 $ 1 253,860 (232,550) 89 21,400
Balances (in shares) at Mar. 31, 2023 3,899,309        
Balances at Mar. 31, 2023 $ 1 203,139 (204,989) 221 (1,628)
Stock-based compensation expense $ 0 2,451 0 0 2,451
Issuance of common stock upon vesting of restricted stock awards (in shares) 544        
Issuance of common stock upon vesting of restricted stock awards $ 0 0 0 0 0
Unrealized loss on available-for-sale securities 0 0 0 6 6
Foreign currency translation adjustments 0 0 0 (53) (53)
Net loss $ 0 0 (25,143) 0 (25,143)
Issuance of common stock (in shares) 2,520,145        
Issuance of common stock $ 0 40,924 0 0 40,924
Balances (in shares) at Jun. 30, 2023 6,419,998        
Balances at Jun. 30, 2023 $ 1 251,484 (230,132) 174 21,527
Issuance of equity-classified warrants 0 4,970 0 0 4,970
Stock-based compensation expense $ 0 2,396 0 0 2,396
Issuance of common stock upon vesting of restricted stock awards (in shares) 543        
Issuance of common stock upon vesting of restricted stock awards $ 0 0 0 0 0
Unrealized loss on available-for-sale securities 0 0 0 (4) (4)
Foreign currency translation adjustments 0 0 0 (81) (81)
Net loss $ 0 0 (2,418) 0 (2,418)
Balances (in shares) at Sep. 30, 2023 6,420,541        
Balances at Sep. 30, 2023 $ 1 253,860 (232,550) 89 21,400
Common stock issuance costs $ 0 (20) 0 0 (20)
Balances (in shares) at Dec. 31, 2023 6,421,084        
Balances at Dec. 31, 2023 $ 1 255,913 (242,723) 199 13,390
Stock-based compensation expense $ 0 2,013 0 0 2,013
Issuance of common stock upon vesting of restricted stock awards (in shares) 543        
Issuance of common stock upon vesting of restricted stock awards $ 0 0 0 0 0
Unrealized loss on available-for-sale securities 0 0 0 (4) (4)
Foreign currency translation adjustments 0 0 0 (55) (55)
Net loss $ 0 0 (11,080) 0 (11,080)
Balances (in shares) at Mar. 31, 2024 6,421,627        
Balances at Mar. 31, 2024 $ 1 257,926 (253,803) 140 4,264
Balances (in shares) at Dec. 31, 2023 6,421,084        
Balances at Dec. 31, 2023 $ 1 255,913 (242,723) 199 13,390
Foreign currency translation adjustments         25
Net loss         $ (25,851)
Exercise of stock options (in shares)         41,090
Balances (in shares) at Sep. 30, 2024 6,857,170        
Balances at Sep. 30, 2024 $ 1 264,225 (268,574) 223 $ (4,125)
Balances (in shares) at Mar. 31, 2024 6,421,627        
Balances at Mar. 31, 2024 $ 1 257,926 (253,803) 140 4,264
Stock-based compensation expense 0 1,951 0 0 1,951
Unrealized loss on available-for-sale securities 0 0 0 2 2
Foreign currency translation adjustments 0 0 0 28 28
Net loss $ 0 0 (6,785) 0 (6,785)
Exercise of stock options (in shares) 12,001        
Exercise of stock options $ 0 36 0 0 36
Balances (in shares) at Jun. 30, 2024 6,433,628        
Balances at Jun. 30, 2024 $ 1 259,913 (260,588) 170 (504)
Stock-based compensation expense 0 2,188 0 0 2,188
Unrealized loss on available-for-sale securities 0 0 0 1 1
Foreign currency translation adjustments 0 0 0 52 52
Net loss $ 0 0 (7,986) 0 (7,986)
Exercise of stock options (in shares) 29,089        
Exercise of stock options $ 0 88 0 0 88
Issuance of common stock (in shares) 394,453        
Issuance of common stock $ 0 2,036 0 0 2,036
Balances (in shares) at Sep. 30, 2024 6,857,170        
Balances at Sep. 30, 2024 $ 1 $ 264,225 $ (268,574) $ 223 $ (4,125)